Clinical Trial Update: Administration of Virus-Specific Cytotoxic T-Lymphocytes [Phase 1]

View source ↗

Summary

Phase 1 trial update on using virus-specific cytotoxic T-lymphocytes to treat adenoviral infection; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoviral Infection

Drugs mentioned

• Virus-Specific Cytotoxic T-Lymphocytes

Snippet

Sponsor: Baylor College of Medicine | Conditions: Adenovirus Infection | Phase 1 | Status: COMPLETED